Tu1727 UPADACITINIB IMPROVES CLINICAL OUTCOMES IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE IRRESPECTIVE OF PREVIOUS FAILURE TO RESPOND TO BIOLOGICS OR CONVENTIONAL THERAPIES
Gastroenterology（2023）
关键词
severely active crohns,clinical outcomes,conventional therapies,upadacitinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要